Merck…big stones to go all in, their flagship PD-1 blocker Keytruda is approaching a patent cliff in 2028. Their stock is hitting the skids over it and could easily be revived. They’ve tasted the rainbow once and could easily be tempted. Biggest selling drug of all time, almost 30 billion in revenue last year…clearly enough green energy to get another “taste”.